175340-20-2,MFCD00952956
Catalog No.:AA00AQUY

175340-20-2 | S 18986

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$46.00   $32.00
- +
5mg
≥98%
in stock  
$199.00   $139.00
- +
10mg
≥98%
in stock  
$306.00   $214.00
- +
25mg
≥98%
in stock  
$652.00   $456.00
- +
100mg
≥98%(HPLC)
in stock  
$2,407.00   $1,685.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00AQUY
Chemical Name:
S 18986
CAS Number:
175340-20-2
Molecular Formula:
C10H12N2O2S
Molecular Weight:
224.2795
MDL Number:
MFCD00952956
SMILES:
O=S1(=O)N[C@H]2CCCN2c2c1cccc2
Properties
Computed Properties
 
Complexity:
349  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.4  

Literature

Title: S 18986 reverses spatial working memory impairments in aged mice: comparison with memantine.

Journal: Psychopharmacology 20110601

Title: DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.

Journal: CNS neuroscience & therapeutics 20101001

Title: New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.

Journal: Journal of medicinal chemistry 20100225

Title: The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.

Journal: Neuropharmacology 20090901

Title: GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986.

Journal: Cell death and differentiation 20090401

Title: Effects of the AMPA receptor modulator S 18986 on measures of cognition and oxidative stress in aged rats.

Journal: Psychopharmacology 20090101

Title: Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.

Journal: Bioorganic & medicinal chemistry 20081201

Title: Behavioral and biological effects of chronic S18986, a positive AMPA receptor modulator, during aging.

Journal: Experimental neurology 20080301

Title: Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil.

Journal: Psychopharmacology 20070701

Title: Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.

Journal: Journal of medicinal chemistry 20070628

Title: S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.

Journal: European journal of pharmacology 20070430

Title: S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat.

Journal: Neuroscience letters 20040506

Title: (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.

Journal: European journal of pharmacology 20000804

Title: Bernard K, et al. DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptorspharmacological profile of a novel cognitive enhancer. CNS Neurosci Ther. 2010 Oct;16(5):e193-212.

Title: Bourasset F, et al. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-,4cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide, in the rat. Drug Metab Dispos. 2005 Aug;33(8):1137-43.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 175340-20-2
Tags:175340-20-2 Molecular Formula|175340-20-2 MDL|175340-20-2 SMILES|175340-20-2 S 18986
Catalog No.: AA00AQUY
175340-20-2,MFCD00952956
175340-20-2 | S 18986
Pack Size: 1mg
Purity: ≥98%
in stock
$46.00 $32.00
Pack Size: 5mg
Purity: ≥98%
in stock
$199.00 $139.00
Pack Size: 10mg
Purity: ≥98%
in stock
$306.00 $214.00
Pack Size: 25mg
Purity: ≥98%
in stock
$652.00 $456.00
Pack Size: 100mg
Purity: ≥98%(HPLC)
in stock
$2,407.00 $1,685.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00AQUY
Chemical Name: S 18986
CAS Number: 175340-20-2
Molecular Formula: C10H12N2O2S
Molecular Weight: 224.2795
MDL Number: MFCD00952956
SMILES: O=S1(=O)N[C@H]2CCCN2c2c1cccc2
Properties
Complexity: 349  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 15  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.4  
Literature fold

Title: S 18986 reverses spatial working memory impairments in aged mice: comparison with memantine.

Journal: Psychopharmacology20110601

Title: DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.

Journal: CNS neuroscience & therapeutics20101001

Title: New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.

Journal: Journal of medicinal chemistry20100225

Title: The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.

Journal: Neuropharmacology20090901

Title: GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986.

Journal: Cell death and differentiation20090401

Title: Effects of the AMPA receptor modulator S 18986 on measures of cognition and oxidative stress in aged rats.

Journal: Psychopharmacology20090101

Title: Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.

Journal: Bioorganic & medicinal chemistry20081201

Title: Behavioral and biological effects of chronic S18986, a positive AMPA receptor modulator, during aging.

Journal: Experimental neurology20080301

Title: Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil.

Journal: Psychopharmacology20070701

Title: Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.

Journal: Journal of medicinal chemistry20070628

Title: S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.

Journal: European journal of pharmacology20070430

Title: S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat.

Journal: Neuroscience letters20040506

Title: (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.

Journal: European journal of pharmacology20000804

Title: Bernard K, et al. DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptorspharmacological profile of a novel cognitive enhancer. CNS Neurosci Ther. 2010 Oct;16(5):e193-212.

Title: Bourasset F, et al. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-,4cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide, in the rat. Drug Metab Dispos. 2005 Aug;33(8):1137-43.

Building Blocks More >
193891-96-2
193891-96-2
N,N-DIALLYL-4-AMINO-BENZENESULFONAMIDE
AA00APYJ | MFCD04528989
175695-32-6
175695-32-6
tert-butyl 2-(2-amino-6-chloro-9h-purin-9-yl)acetate
AA00ARX2 | MFCD31629394
159979-96-1
159979-96-1
1-(Azidomethyl)-4-fluorobenzene
AA00ASBX | MFCD11637153
159471-73-5
159471-73-5
2-Benzyloxy-4-fluoroaniline
AA00ASWH | MFCD09043631
18623-44-4
18623-44-4
4-(5-(3,4-Dimethoxybenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid
AA00ATBT | MFCD00703657
167024-67-1
167024-67-1
2-aMino-2-(4-(trifluoroMethyl)phenyl)acetonitrile
AA00AUJL | MFCD09731430
154343-51-8
154343-51-8
2-Chloro-5,8-dimethoxyquinoline-3-carbaldehyde
AA00AWYK | MFCD02995307
1484-99-7
1484-99-7
2-ETHYLPIPERIDINE HYDROCHLORIDE
AA00AZRY | MFCD09835104
16279-88-2
16279-88-2
4-(1H-1,2,3-Triazol-1-yl)aniline
AA00B32C | MFCD09048597
16619-21-9
16619-21-9
1-(3-Nitrophenyl)-3-phenylprop-2-en-1-one
AA00B5FB | MFCD00024514
Submit
© 2017 AA BLOCKS, INC. All rights reserved.